254 related articles for article (PubMed ID: 15546089)
1. Gynecomastia among HIV-infected patients is associated with hypogonadism: a case-control study.
Biglia A; Blanco JL; Martínez E; Domingo P; Casamitjana R; Sambeat M; Milinkovic A; Garcia M; Laguno M; Leon A; Larrousse M; Lonca M; Mallolas J; Gatell JM
Clin Infect Dis; 2004 Nov; 39(10):1514-9. PubMed ID: 15546089
[TBL] [Abstract][Full Text] [Related]
2. Androgen and gonadotropin patterns differ in HIV-1-infected men who develop lipoatrophy during antiretroviral therapy: a case-control study.
Wunder DM; Fux CA; Bersinger NA; Mueller NJ; Hirschel B; Cavassini M; Elzi L; Schmid P; Bernasconi E; Mueller B; Furrer H;
HIV Med; 2008 Jul; 9(6):427-32. PubMed ID: 18459947
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy.
Rietschel P; Corcoran C; Stanley T; Basgoz N; Klibanski A; Grinspoon S
Clin Infect Dis; 2000 Nov; 31(5):1240-4. PubMed ID: 11073758
[TBL] [Abstract][Full Text] [Related]
4. Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy.
Wunder DM; Bersinger NA; Fux CA; Mueller NJ; Hirschel B; Cavassini M; Elzi L; Schmid P; Bernasconi E; Mueller B; Furrer H;
Antivir Ther; 2007; 12(2):261-5. PubMed ID: 17503668
[TBL] [Abstract][Full Text] [Related]
5. Body image is a major determinant of sexual dysfunction in stable HIV-infected women.
Luzi K; Guaraldi G; Murri R; De Paola M; Orlando G; Squillace N; Esposito R; Rochira V; Zirilli L; Martinez E
Antivir Ther; 2009; 14(1):85-92. PubMed ID: 19320240
[TBL] [Abstract][Full Text] [Related]
6. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
[TBL] [Abstract][Full Text] [Related]
7. Lipoatrophic men 44 months after the diagnosis of lipoatrophy are less lipoatrophic but more hypertensive.
Bergersen BM; Sandvik L; Ellingsen I; Bruun JN
HIV Med; 2005 Jul; 6(4):260-7. PubMed ID: 16011531
[TBL] [Abstract][Full Text] [Related]
8. Association between HLA-B*4001 and lipodystrophy among HIV-infected patients from Thailand who received a stavudine-containing antiretroviral regimen.
Wangsomboonsiri W; Mahasirimongkol S; Chantarangsu S; Kiertiburanakul S; Charoenyingwattana A; Komindr S; Thongnak C; Mushiroda T; Nakamura Y; Chantratita W; Sungkanuparph S
Clin Infect Dis; 2010 Feb; 50(4):597-604. PubMed ID: 20073992
[TBL] [Abstract][Full Text] [Related]
9. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the factors involving in the development of hypothyroidism in HIV-infected patients: a case-control study.
Afhami S; Haghpanah V; Heshmat R; Rasoulinejad M; Izadi M; Lashkari A; Tavangar SM; Hajiabdolbaghi M; Mohraz M; Larijani B
Infection; 2007 Oct; 35(5):334-8. PubMed ID: 17885731
[TBL] [Abstract][Full Text] [Related]
11. Increased prevalence of hypothyroidism among human immunodeficiency virus-infected patients: a need for screening.
Beltran S; Lescure FX; Desailloud R; Douadi Y; Smail A; El Esper I; Arlot S; Schmit JL;
Clin Infect Dis; 2003 Aug; 37(4):579-83. PubMed ID: 12905143
[TBL] [Abstract][Full Text] [Related]
12. A case-control study of gynecomastia in HIV-1-infected patients receiving HAART.
Rahim S; Ortiz O; Maslow M; Holzman R
AIDS Read; 2004 Jan; 14(1):23-4, 29-32, 35-40. PubMed ID: 14959701
[TBL] [Abstract][Full Text] [Related]
13. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
14. Breast enlargement in 13 men who were seropositive for human immunodeficiency virus.
Evans DL; Pantanowitz L; Dezube BJ; Aboulafia DM
Clin Infect Dis; 2002 Nov; 35(9):1113-9. PubMed ID: 12384846
[TBL] [Abstract][Full Text] [Related]
15. Cervical lipomatosis in HIV-infected patients: a case-control study.
Palacios R; Galindo MJ; Arranz JA; Lozano F; Estrada V; Rivero A; Morales D; Asensi V; del Arco A; Muñoz A; Santos J
HIV Med; 2007 Jan; 8(1):17-21. PubMed ID: 17305927
[TBL] [Abstract][Full Text] [Related]
16. Gynaecomastia in HIV-infected men on highly active antiretroviral therapy: association with efavirenz and didanosine treatment.
Mira JA; Lozano F; Santos J; Ramayo E; Terrón A; Palacios R; León EM; Márquez M; Macías J; Fernández-Palacin A; Gómez-Mateos J; Pineda JA;
Antivir Ther; 2004 Aug; 9(4):511-7. PubMed ID: 15456082
[TBL] [Abstract][Full Text] [Related]
17. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
18. Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.
Clifford GM; Rickenbach M; Polesel J; Dal Maso L; Steffen I; Ledergerber B; Rauch A; Probst-Hensch NM; Bouchardy C; Levi F; Franceschi S;
AIDS; 2008 Oct; 22(16):2135-41. PubMed ID: 18832877
[TBL] [Abstract][Full Text] [Related]
19. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
Soria A; Porten K; Fampou-Toundji JC; Galli L; Mougnutou R; Buard V; Kfutwah A; Vessière A; Rousset D; Teck R; Calmy A; Ciaffi L; Lazzarin A; Gianotti N
Antivir Ther; 2009; 14(3):339-47. PubMed ID: 19474468
[TBL] [Abstract][Full Text] [Related]
20. Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384.
Dubé MP; Parker RA; Mulligan K; Tebas P; Robbins GK; Roubenoff R; Grinspoon SK
Clin Infect Dis; 2007 Jul; 45(1):120-6. PubMed ID: 17554712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
